39 |
Use of VH-Findings as Surrogate Marker for Anti-Atherosclerotic Drug |
Duk-Woo Park |
May. 18. 09 |
38 |
Virtual Histology: Clinical Case Examples |
Barry D. Rutherford |
May. 18. 09 |
37 |
Virtual Histology: Clinical Update |
Gary S. Mintz |
May. 18. 09 |
36 |
Virtual Histology: From Thoery to Current Limitations |
William Kongto Hau |
May. 18. 09 |
35 |
Wrapping Up Current Clinical Trials and Future Study Program |
Duk-Woo Park |
Nov. 28. 08 |
34 |
Current Status and Future Perspectives |
Gary S. Mintz |
Nov. 28. 08 |
33 |
Pre-Intervention Assessment and Optimizing Final Result |
Gary S. Mintz |
Nov. 28. 08 |
32 |
VH and OCT Clinical Experience and Future Perspective |
Gary S. Mintz |
Oct. 10. 08 |
31 |
VH AMC Clinical Experience |
Duk-Woo Park |
Oct. 10. 08 |
30 |
VH Registry and Clinical Trial Data Review |
James R. Margolis |
Oct. 10. 08 |